Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Seok-Yeon Kim"'
Autor:
Ki‐Chul Sung, Soon Jun Hong, Moo‐Yong Rhee, Myung‐Ho Jeong, Dae‐Hee Kim, Sang‐Wook Lim, Kyungil Park, Jin Bae Lee, Seok‐Yeon Kim, Jin‐Man Cho, Goo‐Yeong Cho, Jung‐Ho Heo, Sang‐Hyun Kim, Hae‐Young Lee, Weon Kim, Deok‐Kyu Cho, Sungha Park, Jinho Shin, Wook‐Bum Pyun, Kihwan Kwon, Seung‐Woon Rha, Jin‐A Jung
Publikováno v:
The Journal of Clinical Hypertension, Vol 25, Iss 5, Pp 429-439 (2023)
Abstract We compared the efficacy and safety of third‐standard‐dose triple and third‐standard‐dose dual antihypertensive combination therapies in patients with mild to moderate hypertension. This was a phase II multicenter, randomized, double
Externí odkaz:
https://doaj.org/article/d4bd2cdea71e47b8afa576c41b8e9521
Autor:
Eun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, Hyoung-Mo Yang, Moo Hyun Kim, Moo-Yong Rhee, Seung Hwan Han, Jinho Shin, Kwang-il Kim, Jin-Ok Jeong, Ki Chul Sung, Geu Ru Hong, Hyung-Seop Kim, Kihwan Kwon, Tae-Soo Kang, Hae-Young Lee, Su-Eun Han
Publikováno v:
Clinical Hypertension, Vol 28, Iss 1, Pp 1-12 (2022)
Abstract Background To assess the efficacy and safety of a combination therapy involving fimasartan, amlodipine, and rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond to fimasartan monotherapy. Methods This pha
Externí odkaz:
https://doaj.org/article/b2bcd486dbcd485c95d7a3ba8aac16c0
Autor:
Min-gu Kang, Kwang-il Kim, Sang Hyun Ihm, Moo-Yong Rhee, Il Suk Sohn, Hae-Young Lee, Sungha Park, Eun-Seok Jeon, Jong-Min Song, Wook Bum Pyun, Ki-Chul Sung, Moo Hyun Kim, Sang-Hyun Kim, Seok-Yeon Kim, Shin-Jae Kim, Eung Ju Kim, Jinho Shin, Sung Yun Lee, Kook-Jin Chun, Jin-Ok Jeong, Shung Chull Chae, Ki Dong Yoo, Young Jin Choi, Yong Hwan Park, Cheol-Ho Kim
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Hypertension is an important risk factor for cardiovascular disease, even in the elderly. Fimasartan is a new non-peptide angiotensin II receptor blocker with a selective type I receptor blocking effect. The objective of this stud
Externí odkaz:
https://doaj.org/article/50ed1485d82e430f8e9158f9b3a7ee78
Autor:
Seok-Yeon Kim
Publikováno v:
Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi; Jul2024, Vol. 67 Issue 7, p467-474, 8p
Autor:
Jung-Joon Cha, Soon Jun Hong, Ju Hyeon Kim, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Pil Hyung Lee, Seung Whan Lee, Cheol Whan Lee, Jae Youn Moon, Jong-Young Lee, Jung-Sun Kim, Jae Suk Park, Kyounghoon Lee, Sang Yup Lim, Jin Oh Na, Jin-Man Cho, Seok Yeon Kim, Do-Sun Lim
Publikováno v:
American Heart Journal. 261:45-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2586f1c77c9a1c82d8abd8cdb60baa05
https://doi.org/10.1016/j.ahj.2023.03.002
https://doi.org/10.1016/j.ahj.2023.03.002
Autor:
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, Sang-Hyeon Park, Jeehoon Kang, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Seung-Ho Hur, Weon Kim, Seok Yeon Kim, Sang-Hyun Park, Seung Hwan Han, Sang-Hyun Kim, Sanghoon Shin, Yong Hoon Kim, Kyungil Park, Namho Lee, Seung Jin Lee, Jin Won Kim, Hyo-Soo Kim
Publikováno v:
Circulation. 147:1358-1368
Background: Limited data are available on short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention using third-generation drug-eluting stents with ultrathin struts and advanced polymer technology. We investigated whether 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dfaba099293c09b7ac4b7ebd2c5c99a
https://doi.org/10.1161/circulationaha.123.064264
https://doi.org/10.1161/circulationaha.123.064264
Autor:
Kyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, Seung-Woon Rha, Doyeon Hwang, Jeehoon Kang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, Nam-ho Lee, Jay Young Rhew, Kook Jin Chun, Young-Hyo Lim, Jung Min Bong, Jang-Whan Bae, Bong Ki Lee, Seok-Yeon Kim, Won-Yong Shin, Hong-Seok Lim, Kyungil Park, Hyo-Soo Kim
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 9:262-270
Aims The aim of this study was to evaluate the efficacy and safety of prasugrel dose de-escalation therapy in patients with diabetes mellitus (DM)–acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI). Methods and res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f160a8895feca07f2e84f63f602b11a
https://doi.org/10.1093/ehjcvp/pvad008
https://doi.org/10.1093/ehjcvp/pvad008
Autor:
Ki‐Chul Sung, Jung Hoon Sung, Eun Joo Cho, Jeong Cheon Ahn, Seung Hwan Han, Weon Kim, Kye Hun Kim, Il Suk Sohn, Jinho Shin, Seok Yeon Kim, Kwang‐il Kim, Seok Min Kang, Sung‐Ji Park, Yong‐Jin Kim, Joon‐Han Shin, Seong‐Mi Park, Chang‐Gyu Park
Publikováno v:
The Journal of Clinical Hypertension. 24:1298-1309
The aim of this clinical trial was to assess the efficacy and safety of low-dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. After a 2-week placebo run-in period, 176 patients were rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412e37f9152dac92fb3a8306346a3a11
https://doi.org/10.1111/jch.14570
https://doi.org/10.1111/jch.14570
Autor:
Chan Soon Park, Jin Joo Park, Hae-Young Lee, Seok-Min Kang, Byung-Su Yoo, Eun-Seok Jeon, Suk Keun Hong, Joon-Han Shin, Myung-A. Kim, Dae-Gyun Park, Eung-ju Kim, Soon-jun Hong, Seok Yeon Kim, Jae-Joong Kim, Dong-Ju Choi
Publikováno v:
Cardiovascular Drugs and Therapy. 37:529-537
Carvedilol demonstrated therapeutic benefits in patients with heart failure and reduced ejection fraction (HFrEF). However, it had a short half-life time mandating twice a day administration. We investigated whether slow-release carvedilol (carvedilo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d4cc6d196827394e3c16bd68565118
https://doi.org/10.1007/s10557-021-07238-3
https://doi.org/10.1007/s10557-021-07238-3
Autor:
Tae Soo Kang, Taek Jong Hong, Weon Kim, Bong Sik Kim, Jin Man Cho, Soon Jun Hong, Youngkeun Ahn, Jung Sun Kim, Seung-Ah Lee, Joon-Han Shin, Moo Hyun Kim, Moo Yong Rhee, In Ho Chae, Seok Yeon Kim, Cheol Whan Lee, Byung Jin Kim
Publikováno v:
Clinical Therapeutics. 43:1573-1589
PURPOSE We investigated whether the combination therapy of low-intensity rosuvastatin and ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy in patients requiring cholesterol-lowering therapy. METHODS This was a multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf7858af2654422fa020a8fa67a2d9e
https://doi.org/10.1016/j.clinthera.2021.07.016
https://doi.org/10.1016/j.clinthera.2021.07.016